Ventricular dyskinesia is a medical condition characterized by abnormal, uncoordinated movement of the walls of the heart's ventricles during contraction. This disorder disrupts the synchronized pumping action of the heart, leading to inefficient blood circulation. Often associated with underlying heart conditions or cardiac events, ventricular dyskinesia poses significant risks, including impaired cardiac function and an increased likelihood of complications such as heart failure or arrhythmias. Diagnosis typically involves advanced imaging techniques, such as echocardiography, to assess the motion of the heart walls. Treatment strategies may include addressing the underlying cause, managing symptoms, and, in severe cases, surgical interventions to restore normal heart function. Effective management requires a comprehensive approach, often involving collaboration between cardiologists and other healthcare professionals to optimize patient outcomes.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through bio design-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Exploring new biomarkers of cardiomyopathy
Liling Zheng, Fujian Medical University, China